Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, has announced a new extension to its product portfolio, developed specifically for the needs of the single-use bioprocess industry. 

Qosina now offers a selection of components for the design, development and manufacture of single-use systems (SUS).

Scott Herskovitz, Qosina president and CEO, said: “Qosina has been a trusted supplier for over 40 years and has worked with some of the best-known brands. Our experience serving the needs of regulated customers positions us well to expand our products and services for the single-use bioprocess community. We have leveraged this experience and our extensive supply chain to provide a much-needed resource for bioprocess, vaccine production, and cell and gene therapy.”  

Qosina is a one-stop source for single-use bioprocess components, with low minimum order quantities, a liberal sampling policy and bill of material kitting, all supported by regulatory documentation and backed by Qosina’s assurance of supply.

Founded in 1980, Qosina is a global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. 

The company’s catalogue features more than 5,000 products shown in full-scale illustrations on a one-centimetre grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing moulds, and new product design and development. Qosina is ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 cleanroom.